April 15, 2014 – April 15, 2015
Title:
Weiss-Kaufman Psychiatry Self- Assessment Module
Andrea J. Weiss, MD and David Myland Kaufman, MD
Description:
This self-assessment module helps you meet these new standards.
As part of the requirements, physicians must now participate in MOC activities like this one to cultivate lifelong learning and competency. This module helps you hone in on clinical skills that are central to quality patient care and improved.
The American Board of Psychiatry and Neurology (ABPN) has reviewed the Weiss-Kaufman Psychiatry Self-Assessment Module and has approved it as part of a comprehensive self-assessment program, which is mandated by the American Board of Medical Specialties (ABMS) as a necessary component of MOC.
Learning Objectives:
At the end of this educational activity, participants should be able to:
- Recognize the presentation of psychiatric disorders
- Diagnose and treat patients with psychiatric disorders
Target Audience:
The target audience for this module is psychiatrists.
Pricing:
$50 if participant has attended a Kaufman Course
$160 if the participant has not attended a Kaufman Course
Faculty Contributors:
|
Merrill S. Herman, MD Associate Professor of Clinical Psychiatry and Behavioral Sciences Department of Psychiatry and Behavioral Sciences Albert Einstein College of Medicine Montefiore Medical Center Bronx, NY
David M. Kaufman, MD Professor, Department of Neurology Professor, Department of Psychiatry Department of Psychiatry and Behavioral Sciences Albert Einstein College of Medicine Montefiore Medical Center Bronx, NY John M. Kenny, MD Assistant Professor Department of Psychiatry and Behavioral Sciences Albert Einstein College of Medicine Bronx Psychiatric Center Bronx, NY
Stephen E. Nicolson, MD Director, Adult Psychiatry Consult Service Associate Professor of Psychiatry
|
Louise Ruberman, MD Associate Professor Department of Psychiatry and Behavioral Sciences Bronx Children’s Psychiatric Center Albert Einstein College of Medicine Montefiore Medical Center Bronx, NY
Bruce J. Schwartz, MD Deputy Chairman and Professor of Clinical Psychiatry and Behavioral Sciences Department of Psychiatry and Behavioral Sciences Albert Einstein College of Medicine Montefiore Medical Center Bronx, NY
Andrea J. Weiss, MD Associate Clinical Professor Department of Psychiatry and Behavioral Sciences Albert Einstein College of Medicine Montefiore Medical Center Bronx, NY
|
CME Information:
Release Date: April 15, 2014
Latest Review: Dr. Andrea Weiss on April 10, 2014
Expiration Date: April 15, 2015
To receive credit for this activity, complete the module, complete the evaluation, and enter the required information.
Accreditation Statement:
Albert Einstein College of Medicine of Yeshiva University is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.
Albert Einstein College of Medicine of Yeshiva University designates this internet activity for a maximum of 8 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hardware/Software Specifications:
This internet-based CME activity is best experienced using Google Chrome, Internet Explorer 8+, Mozilla Firefox 3+, Safari 4+. This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Adobe Acrobat, Microsoft PowerPoint, and Windows Media Player.
Optimal System Configuration:
Flash Player: Adobe Flash Player 10.1+
Browser: Firefox 3+, Internet Explorer 8.0+, Safari 4.0+, or Google Chrome 7.0+
Operating System: Windows XP+ or Mac OS X 10.4+
Internet Connection: 1 Mbps or higherMinimum Requirements: Windows XP or higher;
Macintosh:
Mac OS X 10.3 or higher with latest updates installed;
Conflict of Interest Statement:
The Conflict of interest Disclosure Policy at Albert Einstein of College of Medicine of Yeshiva University requires that faculty participating in any CME activity disclose to the audience any relationships with a pharmaceutical or equipment company. Any presenter whose disclosed relationship proves to create a conflict of interest, with regard to their contribution to the activity, will not be permitted to present.
Albert Einstein College of Medicine of Yeshiva University also requires faculty participating in any CME activity disclose to audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
The staff of CCME of Albert Einstein College of Medicine of Yeshiva University have no conflicts of interest with commercial interests related directly or indirectly to this educational activity.
The following faculty have indicated that they have no disclosures:
David M. Kaufman, MD John M. Kenny, MD
Stephen E. Nicolson, MD Louise Ruberman, MD
Bruce J. Schwartz, MD Andrea J. Weiss, MD
The following faculty have indicated that they will be discussing unlabeled or investigational use of a commercial product or device not yet approved for use in the United States.
Merrill S. Herman, MD ― Seroquel & Neurontin
Stephen E. Nicolson, MD ― Unlabeled uses discussed in recertification presentation: Amiloride for diabetes insipidus. Androgens in the treatment of hypoactive sexual desire Anti-androgens in the treatment of paraphilias. Beta-blockers in the treatment of hyperthyroidism. Buspirone for hypoactive sexual desire and SSRI induced sexual dysfuntion. Clomipramine in the treatment of body dysmorphic disorder. Cyproheptadine for SSRI induced sexual dysfunction. Dimercaptosuccinic acid in arsenic poisoning. Diuretics for diabetes insipidus. Dopamine blockers in the treatment of itching and migraines. Estradiol in the treatment of gender identity disorder (transsexualism). Ethanol for methanol and ethylene glycol poisoning. Fluoxetine in the treatment of menopausal hot flashes. Haloperidol in the treatment of delirium. Hydrochlorothiazide for diabetes insipidus. Lorazepam in the treatment of alcohol withdrawal. Metoclopramide in the treatment of nausea. Paroxetine in the treatment of menopausal hot flashes. Phosphodiesterase inhibitors in the treatment of premature ejaculation and orgasmic disorder. Sildenafil in the treatment of female arousal disorder. Serotonin and norepinephrine reuptake inhibitors (SNRIs) in the treatment of fibromyalgia. Selective serotonin reuptake inhibitors (SSRIs) in the treatment of body dysmorphic disorder, fibromyalgia, pain, irritable bowel, paraphilias, and premature ejaculation. Stimulants in the treatment of depression, pain, and hypoactive sexual desire. Tricylic antidepressants (TCAs) in the treatment of fibromyalgia, pain, irritable bowel, and premature ejaculation.Testosterone in the treatment of AIDS-wasting syndrome, depression, and gender identity disorder (transsexualism). Venlafaxine in the treatment of menopausal hot flashes.Yohimbine for sexual dysfunction.
Louise Ruberman, MD ― (syllabus only) Methylphenidate (regular, short-acting), Daytrana in the treatment of ADHD in adults; Buproprion, Alpha 2 Agonists (Clonidine and Guanfacine), Tricyclic Antidepressants (eg Desipramine, Nortriptyline) in the treatment of ADHD in adults and children; Atomoxetine in the treatment of ADHD + Social Phobia in adults and children; “Stimulants” – any preparation, SSRIs (eg Fluoxetine), Risperdal (only approved for irritability in children 5+; all other uses in children or adults off-label in the treatment of Autistic Disorders in adults and children; Atypical Antipsychotics (eg Risperdal), any “stimulant” preparation, Alpha 2 Agonists (eg Guanfacine, Clonidine) in the treatment of Tourette’s Disorder in adults and children
Special Needs:
Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center comply with the Americans with Disability Act. Should you need assistance, please contact Jerilyn Saalman – Program Coordinator/Administration of the Department of Psychiatry at Montefiore Medical Center. Her number is 718-920-7967 or she can be reached at jsaalman@montefiore.org.
